Analysts think OLMA stock price could increase by 398%
Dec 28, 2024, 12:25 PM
-3.25%
What does OLMA do
Olema Pharmaceuticals, based in San Francisco, develops targeted therapies for women's cancers, notably its lead candidate OP-1250, currently in Phase I/II trials for metastatic ER-positive breast cancer. The company went public on November 19, 2020, and employs 75 staff.
9 analysts think OLMA stock price will increase by 397.56%. The current median analyst target is $30.60 compared to a current stock price of $6.15. The lowest analysts target is $20.20 and the highest analyst target is $31.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.